The paper by Brabin et al. [1] in this issue of the Food and Nutrition Bulletin, consisting of an epidemiological cross-sectional study of women attending health posts and post-partum centres in Mumbai, India, points out very clearly several important and commonly observed facts regarding the haematological status of women of child-bearing age, particularly but not exclusively in the developing world. The following points are noteworthy from the policy point of view.
Results of primary health care in Matlab, Bangladesh
The authors believe that iron supplementation was the major factor responsible for the observed improvement in iron status that was found in the Matlab population surveys [1] . However, they do not prove it, because there was no true control group and other interventions were also occurring. Nevertheless, the data illustrate that the Matlab primary health-care programme, which included iron supplementation, was effective, and this should be an additional stimulus to the development of similar programmes in other countries. Another paper recently published in Lancet describes a decline in maternal mortality in the same popu-lation but cautions that the intervention programmes rely, at the very least, on the functioning of the entire health-care system and on effective referral and communication strategies to promote specific behaviours. It was noted that "One indicator will not be sufficient to elucidate the complex nature of such programmes, and various assessment techniques and indicators are required" [2] . Even if iron supplementation alone were sufficient to achieve the specific goal of correcting iron deficiency, it would not be a substitute for the other health measures in the Matlab programme.
Prevention of anaemia in women of child-bearing age
respectively). Anaemia was defined on the basis of the World Health Organization proposed cut-off points of 110 g/L haemoglobin for women in early pregnancy (<15 weeks gestation) and 120 g/L for non-pregnant women. The fact that even with a cut-off 10 g/L lower for early pregnancy, the prevalence of anaemia is as high in this population as it is among non-pregnant women suggests either that gestational haemodilution occurs early or that even the small demands of erythropoietic nutrients early in pregnancy will produce anaemia.
The absence of severe anaemia (<80 g/L) is important to note, even when mean haemoglobin values ranged from 97 to 114 g/L. The distribution of haemoglobin values shown in figure 1 is skewed to the right, except for the post-partum group, which shows a very symmetrical distribution. In this group, the proportion of women with haemoglobin levels <90 g/L is lower than in non-pregnant women or women in early pregnancy. This finding would appear paradoxical, because post-partum women generally are more anaemic than non-pregnant women. A possible explanation for this finding could be that supplementation with iron and folate during pregnancy temporarily improved postpregnancy haematological status. This interpretation may be supported by the apparently small effects of multiparity. On the other hand, pregnancy appears to have a long-term effect on haemoglobin levels, as evidenced by higher haemoglobin levels among women who have never been pregnant, women with "no live births," and women with "0 years since first pregnancy" than among the other three groups (table 1) .
The results of multivariate analysis, including as independent variables women's education, socio-economic status, number of pregnancies and live births, and age at menarche, explain only 16% of the variance in haemoglobin levels, leaving a large proportion of unexplained variance according to this model. Unfortunately, there is no information on biochemical indicators that could point in the direction of possible causes of low haemoglobin, such as meal composition, cooking methods, overall dietary intakes, infection rates, or even approximate menstrual blood losses, that are expected to account for most of the rest of the variance. Even though the authors do not speculate on causality, their discussion and recommendations suggest that underlying the problem is poor diet, leading most probably to iron and vitamin A, and possibly to folate and/or vitamin B 12 deficiencies. In spite of these limitations, education, reproductive history, and age at menarche (as a surrogate for general nutritional status before and during puberty) are significant.
From these salient facts, the authors suggest that policies directed to improve the health and education of girls and the survival of children, reduce the number of pregnancies, and provide iron + folate supplementation during pregnancy are important to reduce the high prevalence of anaemia in the women of Mumbai. However, they acknowledge that these measures may have only a limited impact, and go a step further in their recommendations: "Health promotion to improve the diet of girls and iron supplementation in adolescence are required to redress nutritional deficits and, in the longer term, to reduce anaemia in older women of reproductive age…governments are starting to draw up national policy guidelines to improve adolescent sexual and reproductive health. Nutritional information and supplementation should be included in these policies, and every effort should be made to link supplementation to other interventions reaching young girls."
Experimental animal, clinical, and population studies strongly suggest that community-based, preventive iron + folate supplementation, ideally combined with other nutrients deficient in the diet (e.g., vitamin A) should be targeted to vulnerable groups, in particular to small children and women of reproductive age (whether or not they are pregnant). This strategy could be implemented in the short term in areas where foodbased approaches (i.e, food fortification and significant dietary improvement) cannot be achieved in the short or medium term. Focusing on fertile adolescents and adult women, the purpose of this strategy is to complement all other possible strategies, pertinently suggested by the paper by Brabin et al., but with the further aim that all women enter pregnancy with adequate iron reserves and a superior folate nutritional status.
The findings of the study of Brabin et al. suggest that iron + folate supplementation should start before pregnancy, and at least as early as possible during pregnancy. Providing 100 tablets of iron + folate late in pregnancy and without any mechanism that will promote their proper ingestion has proven, at most, only minimally effective. Effective preventive supplementation is most likely to occur through community action in coordination with the health posts and post-partum centres. Several trials in which schoolteachers provided weekly iron + folate tablets to schoolgirls (and boys in some cases) throughout the school year are demonstrating an improvement in iron nutrition, including the correction of moderate anaemia (as seen in Mumbai women) and, most importantly, a progressive and safe increment of iron reserves [2, 3] Similarly, in women of childbearing age, the results of ingestion of one tablet a week containing 60 mg of iron and 250 mg of folate in the course of seven months, for a total of 30 tablets, were as good as or better than the results of daily ingestion of tablets of the same composition but only for the first three months of the total seven-month trial (totaling 90 tablets) [4] .
Equally important is the information and motivation of the whole community through mass media and the formation of community groups (e.g., based on educational, religious, industrial, and market activities), and especially women's groups, that can ensure the weekly ingestion of tablets by any woman who may become pregnant, and to double the dose as soon as pregnancy occurs (not waiting until the second or the last trimester of pregnancy). Coverage of the vulnerable population can also be increased in this fashion.
Several studies of pregnant women clearly indicate that initial haemoglobin concentration is the most important determinant of haemoglobin concentration at term, and that the duration of supplementation is more important than the dose of iron. Thus, the better the pre-pregnancy iron nutritional status, the more effective iron + folate supplementation during pregnancy can be. Ideally, women should enter pregnancy with 300 mg of iron reserves. Very few women in the developing world and almost half the women in industrial countries do not have these reserve levels. Currently, if women are already clearly anaemic during pregnancy (haemoglobin <90 g/L), they are treated by daily administration of iron. This practice should be continued and carefully evaluated, especially when haemoglobin levels are lower than 80 g/L. However, several studies suggest that supervised weekly iron supplemen-tation with proper doses covering at least 15 weeks during pregnancy can be almost as efficacious as daily supplementation [4] [5] [6] [7] [8] .
In conclusion, this paper provides strong support for targeting interventions for the prevention of anaemia in the community as a whole and especially in pubertal, adolescent, and mature fertile women and not concentrating iron + folate supplementation strategies only on pregnant women during the second or third gestational trimesters. In most developing country settings, iron + folate supplementation restricted to or starting during the last half of pregnancy has proven ineffective [9] [10] [11] .
Professor Fernando Viteri Department of Nutritional Sciences
University of California, Berkeley Berkeley, CA, USA
Stability of potassium iodate as an additive to salt
The research by L. L. Diosady, J. O. Alberti, M. G. Venkatesh Mannar, and S. FitzGerald published in this issue of the Food and Nutrition Bulletin [1] and the earlier paper on the same topic published in the Bulletin [2] merit comment. The investigators invested a great deal of effort in the technical aspects of the research, including the laboratory procedures and careful control of artificial environmental conditions. Nevertheless, the narrow scope of the experimental plan, which considers only two climatic conditions (40°C at 100% relative humidity and 40°C at 60% relative humidity) severely limits the usefulness and potential application of the research findings. Extensive areas in many developing countries with less drastic conditions of environmental temperature and humidity are heavily populated by people suffering from iodine-deficiency disorders. It would have been a valuable additional effort not only to use samples of
